Novo Nordisk's repurchase program is operating under the regulations of the European Union.
3 reports, 2 independent
Updated Tue 00:00
No new developments lately
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Novo Nordisk's repurchase program is operating under the regulations of the European Union.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Novo Nordisk ADRs are listed on NYSE while its repurchase program adheres to EU rules.1 source
Novo Nordisk buyback program operates under EU regulation.1 source
Keep exploring
The entities involved
-
Novo Nordisk
Danish pharmaceutical company
- Major pharmaceutical companies, including Viking Therapeutics, Eli Lilly, and Novo Nordisk, are advancing their weight loss drug pipelines.
- Eli Lilly and Company received full FDA approval, expanded a safety study into India, and broke ground on a new facility in Houston while competing in the GLP-1 market.
Coverage
Newest first; wire copies grouped- investegate.co.uk
- foreignpolicyjournal.com
- foreignpolicyjournal.comNovo Nordisk (NYSE: NVO) Advances DKK 15 Billion Share Buyback With Fresh Weekly Transactions